Rock Creek Group, LP Biogen Inc. Transaction History

Rock Creek Group, LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $3,039 - $3,430	12 Added 150.0%	20 $5,000
Q2 2023 Aug 09, 2023	BUY	$275.25 - $318.06 $2,202 - $2,544	8 New	8 $2,000
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $3,115 - $4,295	-16 Reduced 61.54%	10 $3,000
Q1 2022 May 11, 2022	BUY	$193.77 - $244.14 $5,038 - $6,347	26 New	26 $5,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $848 - $1,107	-3 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $1,813 - $2,902	-7 Reduced 70.0%	3 $1,000
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $2,429 - $2,846	10 New	10 $3,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $115,531 - $173,903	-489 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$264.77 - $305.71 $75,459 - $87,127	-285 Reduced 36.82%	489 $139,000
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $6,207 - $8,221	24 Added 3.2%	774 $207,000
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $201,637 - $255,780	750 New	750 $237,000
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $278,975 - $312,898	-1,283 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $24,779 - $27,314	-113 Reduced 8.09%	1,283 $300,000
Q1 2019 May 10, 2019	SELL	$216.71 - $338.96 $81,699 - $127,787	-377 Reduced 21.26%	1,396 $330,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $233,940 - $296,310	840 Added 90.03%	1,773 $534,000
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $273,844 - $358,113	933 New	933 $330,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

Stay updated on Rock Creek Group, LP with notifications on news.